TMS JAPAN
TMS is a research on medical products, medical products, medical products, medical equipment and medical consumables.
TMS JAPAN
Industry:
Medical Device
Founded:
2005-02-17
Address:
Fuchu, Tokyo, Japan
Country:
Japan
Website Url:
http://www.tms-japan.co.jp
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
700 M JPY
Current Employees Featured
Founder
Investors List
77 Capital
77 Capital investment in Venture Round - TMS Japan
Nissay Capital
Nissay Capital investment in Venture Round - TMS Japan
Tohoku University Venture Partners
Tohoku University Venture Partners investment in Venture Round - TMS Japan
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC)
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC) investment in Venture Round - TMS Japan
More informations about "TMS Japan"
HOME | TMS Co., Ltd. - tms-japan.co.jp
Dec 18, 2024 TMS to participate in Precision AQ Corporate Access Event During J.P.Morgan 2025 Week in San Francisco ๏ผ201KB๏ผ Nov 15, 2024 TMS Co., Ltd. CEO Takuro Wakabayashi Interviewed on US Internet News Media 'Biotech โฆSee details»
About Us | TMS Co., Ltd. - tms-japan.co.jp
You can see the About Us of TMS Co., Ltd..See details»
Company Info | About Us | TMS Co., Ltd. - tms-japan.co.jp
Address. Headquaters: 1-9-11F, Fuchu-cho, Fuchu-shi, Tokyo 183-0055, JAPANSee details»
TMS - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +81-42-306-5087 TMS is a Tokyo-based clinical-stage biotech company that unlocks fungus-derived SMTP small molecule compound group.See details»
TMS Japan - Crunchbase Company Profile & Funding
Organization. TMS Japan . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. ... Legal Name TMU Science Co., Ltd. Company Type For Profit; โฆSee details»
Developing revolutionary drugs for diseases without โฆ
Initial research efforts were concentrated on TMS-007, an SMTP compound. TMS-007, which dissolves blood clots and controls inflammation, is anticipated to be highly effective for treating acute ischemic strokes. TMS stepped up its โฆSee details»
TMS CO., LTD. Company Profile | FUCHU, TOKYO, Japan
Find company research, competitor information, contact details & financial data for TMS CO., LTD. of FUCHU, TOKYO. Get the latest business insights from Dun & Bradstreet.See details»
Management Team | About Us | TMS Co., Ltd. - tms-japan.co.jp
During his tenure at TMS, he led deals with Biogen and Ji-Xing (now CORXEL) and led the companyโs initial public offering in 2022, which is the first global IPO by a Japan-based biotech โฆSee details»
TMS - Overview, News & Similar companies | ZoomInfo.com
Who is TMS. TMS Co., Ltd. is aprivately held, clinical stage biotechnology company based in Fuchu-shi, Tokyo. The company was founded in 2005 to develop therap eutics based on novel โฆSee details»
TMS CO., LTD. Company Profile | KOSHIGAYA, SAITAMA, Japan
Find company research, competitor information, contact details & financial data for TMS CO., LTD. of KOSHIGAYA, SAITAMA. Get the latest business insights from Dun & Bradstreet.See details»
History | About Us | TMS Co., Ltd. - tms-japan.co.jp
In June 2018, TMS signed an option agreement to assign TMS-007, its lead program indicating acute ischemic stroke, and related assets to Biogen for a total of $ 357 million milestone โฆSee details»
TMS (Drug Discovery) Company Profile 2025: Stock ... - PitchBook
May 10, 2021 TMS Co Ltd is engaged in the research and development of pharmaceuticals, quasi-drugs, pharmaceutical raw materials, medical equipment and medical consumables. โฆSee details»
TMS Company Profile - Office Locations, Competitors, Revenue
TMS (Transcranial Magnetic Stimulator) Market ($2.02Bn by 2028) Growth Forecast at 8.8% CAGR During (2021-2028) - COVID-19 Impact and Global Analysis by โฆSee details»
Board of Directors | About Us | TMS Co., Ltd. - tms-japan.co.jp
Takanashi brings into TMS deep global business experience in biomedical field. Mr. Takanashi currently serves as Executive Vice President, Head of Global Business at Shin Nippon โฆSee details»
Working at TMS (Japan) - Glassdoor
Glassdoor gives you an inside look at what it's like to work at TMS (Japan), including salaries, reviews, office photos, and more. This is the TMS (Japan) company profile. All content is โฆSee details»
Corporate Presentation - tms-japan.co.jp
Transferred ex-Japan rights from Biogen to CORXEL January 2024 JX09 (Resistant or uncontrolled hypertension) First subject dosed in Ph1 study in Australia February 2024 In โฆSee details»
Corporate Presentation | IR Library | Investor Relations | TMS Co., Ltd.
You can see the Corporate Presentation of TMS Co., Ltd..See details»
Pipeline | Business | TMS Co., Ltd. - tms-japan.co.jp
Cookie Policy. We use cookies to provide you with a better browsing experience. Please confirm that you agree to our use of cookies by clicking Yes.See details»